Case report: a 10-year-old girl with primary hypoparathyroidism and systemic lupus erythematosus-Reference-Cited by-同舟云学术

Case report: a 10-year-old girl with primary hypoparathyroidism and systemic lupus erythematosus

Published:2020-08-27 Issue:9 Volume:33 Page:1231-1235
ISSN:2191-0251
Container-title:Journal of Pediatric Endocrinology and Metabolism
language:en
Short-container-title:

Author:

Borysewicz-Sańczyk Hanna¹^ORCID,Sawicka Beata¹,Michalak Justyna¹,Wójtowicz Jerzy¹,Dobreńko Elżbieta²,Konstantynowicz Jerzy²,Kemp E. Helen³,Thakker Rajesh V.⁴,Allgrove Jeremy⁵,Hannan Fadil M.⁴⁶,Bossowski Artur¹^ORCID

Affiliation:

1. Department of Pediatrics, Endocrinology, Diabetology with a Cardiology Division, Medical University of Bialystok , Białystok , Poland

2. Department of Pediatrics, Rheumatology, Immunology and Metabolic Bone Diseases, Medical University of Bialystok , Białystok , Poland

3. Department of Oncology and Metabolism, University of Sheffield , Sheffield , UK

4. Academic Endocrine Unit, Radcliffe Department of Medicine, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford , Oxford , UK

5. Department of Pediatric Endocrinology, Great Ormond Street Hospital for Children , London , UK

6. Nuffield Department of Women’s & Reproductive Health, University of Oxford , Oxford , UK

Abstract

Abstract Objectives Hypoparathyroidism is a rare disease in children that occurs as a result of autoimmune destruction of the parathyroid glands, a defect in parathyroid gland development or secondary to physical parathyroid gland disturbance. Typical symptoms of hypoparathyroidism present as hypocalcaemia and hyperphosphatemia due to decreased parathyroid hormone secretion and may lead to nerve and muscles disturbances resulting in clinical manifestation of tetany, arrhythmias and epilepsy. Currently, there is no conventional hormone replacement treatment for hypoparathyroidism and therapeutic approaches include normalising mineral levels using an oral calcium supplement and active forms of vitamin D. Case presentation We present the case of a 10-year-old girl with primary hypoparathyroidism who had no prior history of autoimmune disorders, but who subsequently developed systemic lupus erythematosus.

Publisher

Walter de Gruyter GmbH

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Pediatrics, Perinatology, and Child Health

Link

https://www.degruyter.com/document/doi/10.1515/jpem-2020-0015/pdf

Reference14 articles.

1. Liu, MJ, Li, JW, Shi, XY, Hu, LY, Zou, LP. Epileptic seizure, as the first symptom of hypoparathyroidism in children, does not require antiepileptic drugs. Childs Nerv Syst 2017;33:297–305. https://doi.org/10.1007/s00381-016-3264-2.

2. Yoo, DY, Kim, HJ, Cho, KH, Kwon, EB, Yoo, EG. Delayed diagnosis of 22q11 deletion syndrome due to late onset hypocalcemia in an 11-year-old girl with imperforated anus. Ann Pediatr Endocrinol Metab 2017;22:133–8. https://doi.org/10.6065/apem.2017.22.2.133.

3. Mishra, PE, Schwartz, BL, Sarafoglou, K, Hook, K, Kim, Y, Petryk, A. Short-term PTH(1–34) therapy in children to correct severe hypocalcemia and hyperphosphatemia due to hypoparathyroidism: two case studies. Case Rep Endocrinol 2016;2016:1–4. https://doi.org/10.1155/2016/6838626.

4. Nordenström, E, Bergenfelz, A, Almquist, M. Permanent hypoparathyroidism after total thyroidectomy in children: results from a national registry. World J Surg 2018;42:2858–63. https://doi.org/10.1007/s00268-018-4552-7.

5. Sahebari, M, Afkhamizadeh, M, Hashemzadeh, K, Pezeshki Rad, M. Development of systemic lupus erythematosus in a patient with hypoparathyroidism: a case report and review of the literature. Int J Rheum Dis 2010;13:175–9. https://doi.org/10.1111/j.1756-185x.2010.01464.x.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of hypoparathyroidism: a Position Statement of the Expert Group of the Polish Society of Endocrinology;Endokrynologia Polska;2023-10-30

2. New Approach to Addison Disease: Oral Manifestations Due to Endocrine Dysfunction and Comorbidity Burden;Diagnostics;2022-08-28

3. Oxcarbazepine;Reactions Weekly;2020-12